Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?

Colorectal cancer (CRC) is presently one of the most common causes of cancer-related death in our setting and affects a great number of people each year. Screening strategies are commonly used but they do not seem enough to avoid CRC development or prevent completely its mortality. Because of this f...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Manzano, P. Pérez-Segura
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/2012/327341
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554728075034624
author A. Manzano
P. Pérez-Segura
author_facet A. Manzano
P. Pérez-Segura
author_sort A. Manzano
collection DOAJ
description Colorectal cancer (CRC) is presently one of the most common causes of cancer-related death in our setting and affects a great number of people each year. Screening strategies are commonly used but they do not seem enough to avoid CRC development or prevent completely its mortality. Because of this fact other prevention strategies have gained interest in recent years. Chemoprevention seems to be an attractive option in this setting and several drugs have been studied in this field. This review is focused on salicylates, nonsteroidal anti-inflammatory drugs (NSAIDs) and cycloxygenase-2 inhibitors (COXIBs), whose mechanism of action could be directly related to colon cancer chemoprevention.
format Article
id doaj-art-aef3e8a29d0b4447a9df81d8da961746
institution Kabale University
issn 1537-744X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-aef3e8a29d0b4447a9df81d8da9617462025-02-03T05:50:43ZengWileyThe Scientific World Journal1537-744X2012-01-01201210.1100/2012/327341327341Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?A. Manzano0P. Pérez-Segura1Oncology Department, Hospital Clínico San Carlos, 28040 Madrid, SpainOncology Department, Hospital Clínico San Carlos, 28040 Madrid, SpainColorectal cancer (CRC) is presently one of the most common causes of cancer-related death in our setting and affects a great number of people each year. Screening strategies are commonly used but they do not seem enough to avoid CRC development or prevent completely its mortality. Because of this fact other prevention strategies have gained interest in recent years. Chemoprevention seems to be an attractive option in this setting and several drugs have been studied in this field. This review is focused on salicylates, nonsteroidal anti-inflammatory drugs (NSAIDs) and cycloxygenase-2 inhibitors (COXIBs), whose mechanism of action could be directly related to colon cancer chemoprevention.http://dx.doi.org/10.1100/2012/327341
spellingShingle A. Manzano
P. Pérez-Segura
Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
The Scientific World Journal
title Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
title_full Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
title_fullStr Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
title_full_unstemmed Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
title_short Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
title_sort colorectal cancer chemoprevention is this the future of colorectal cancer prevention
url http://dx.doi.org/10.1100/2012/327341
work_keys_str_mv AT amanzano colorectalcancerchemopreventionisthisthefutureofcolorectalcancerprevention
AT pperezsegura colorectalcancerchemopreventionisthisthefutureofcolorectalcancerprevention